Hydrocortisone composition having enhanced bioavailability and percutaneous absorption
US4738956A · kind A · utility
15Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 1986 |
| Grant date | Apr 19, 1988 |
| Priority date | — |
| Expiry date | Dec 15, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new and improved topically applied pharmaceutical preparation for the treatment of itching, rash, eczema, insect bites, poison ivy and the like and an improved vehicle for delivering the active ingredients thereof to the human skin in a manner whereby the bioavailability and percutaneous absorption of the active ingredient is remarkably enhanced. The vehicle comprises a volatile silicone, a fatty alcohol having from 12-22 carbon atoms, hydrocortisone; and such preservatives or emulsifying agents as may be warranted.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.